Exact Mass: 370.0851

Exact Mass Matches: 370.0851

Found 81 metabolites which its exact mass value is equals to given mass value 370.0851, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Thiophanate

ethoxy({[(2-{N-[ethoxy(hydroxy)methylidene]-(C-sulfanylcarbonimidoyl)amino}phenyl)thio(carbonoimidyl)]imino})methanol

C14H18N4O4S2 (370.0769)


CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8618; ORIGINAL_PRECURSOR_SCAN_NO 8617 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4116; ORIGINAL_PRECURSOR_SCAN_NO 4115 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4103; ORIGINAL_PRECURSOR_SCAN_NO 4099 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4122; ORIGINAL_PRECURSOR_SCAN_NO 4120 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8587; ORIGINAL_PRECURSOR_SCAN_NO 8585 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4090; ORIGINAL_PRECURSOR_SCAN_NO 4085 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8620; ORIGINAL_PRECURSOR_SCAN_NO 8618 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8603; ORIGINAL_PRECURSOR_SCAN_NO 8601 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8583; ORIGINAL_PRECURSOR_SCAN_NO 8581 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4112; ORIGINAL_PRECURSOR_SCAN_NO 4109 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8619; ORIGINAL_PRECURSOR_SCAN_NO 8617 CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4113; ORIGINAL_PRECURSOR_SCAN_NO 4112 ORIGINAL_PRECURSOR_SCAN_NO 8618; CONFIDENCE standard compound; INTERNAL_ID 1255; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8620 D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D016573 - Agrochemicals D010575 - Pesticides

   

Fraxin

InChI=1/C16H18O10/c1-23-7-4-6-2-3-9(18)25-14(6)15(11(7)20)26-16-13(22)12(21)10(19)8(5-17)24-16/h2-4,8,10,12-13,16-17,19-22H,5H2,1H3/t8-,10-,12+,13-,16+/m1/s

C16H18O10 (370.09)


Fraxin is a beta-D-glucoside that is fraxetin attached to a beta-D-glucopyranosyl group at position 8 via a glycosidic linkage. It is a natural product isolated from the leaves of Fraxinus excelsior and exhibits potent hepatoprotective effects in vitro and in vivo. It has a role as a plant metabolite, an anti-inflammatory agent and a hepatoprotective agent. It is a beta-D-glucoside, a hydroxycoumarin and an aromatic ether. It is functionally related to a fraxetin. Fraxin is a natural product found in Acer nikoense, Prunus prostrata, and other organisms with data available. A beta-D-glucoside that is fraxetin attached to a beta-D-glucopyranosyl group at position 8 via a glycosidic linkage. It is a natural product isolated from the leaves of Fraxinus excelsior and exhibits potent hepatoprotective effects in vitro and in vivo. Origin: Plant, Coumarins Fraxin isolated from Cortex Fraxini, is a glucoside of fraxetin and reported to exert potent anti-oxidative stress action[1], anti-inflammatory and antimetastatic properties. Fraxin shows its antioxidative effect through inhibition of cyclo AMP phosphodiesterase enzyme[2]. Fraxin isolated from Cortex Fraxini, is a glucoside of fraxetin and reported to exert potent anti-oxidative stress action[1], anti-inflammatory and antimetastatic properties. Fraxin shows its antioxidative effect through inhibition of cyclo AMP phosphodiesterase enzyme[2].

   

Sodium equilin sulfate

Sodium equilin sulfate

C18H19O5S. Na (370.0851)


   

5-Hydroxy-6-methoxycoumarin 7-glucoside

5-hydroxy-6-methoxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2H-chromen-2-one

C16H18O10 (370.09)


5-Hydroxy-6-methoxycoumarin 7-glucoside is found in alcoholic beverages. 5-Hydroxy-6-methoxycoumarin 7-glucoside is isolated from Prunus spinosa (sloe). Isolated from Prunus spinosa (sloe). 5-Hydroxy-6-methoxycoumarin 7-glucoside is found in alcoholic beverages, herbs and spices, and fruits.

   

Remoxipride

3-bromo-N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2,6-dimethoxybenzamide

C16H23BrN2O3 (370.0892)


Remoxipride is only found in individuals that have used or taken this drug. It is an antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia. [PubChem]Remoxipride acts as an antagonist at the D2 dopamine receptor. It is believed that overactivity of dopamine systems in the mesolimbic pathway may contribute to the "positive symptoms" of schizophrenia (such as delusions and hallucinations), whereas problems with dopamine function in the mesocortical pathway may be responsible for the "negative symptoms", such as avolition, flat emotional response and alogia. Therefore, by decreasing the levels of dopamine in these pathways, it is thought that remoxipride is able to reduce the symptoms of schizophrenia, particularily the "positive symptoms". D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AL - Benzamides C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

   

Ferulic acid 4-O-glucuronide

(2S,3S,4S,5R,6S)-6-{4-[(1E)-2-carboxyeth-1-en-1-yl]-2-methoxyphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C16H18O10 (370.09)


Ferulic acid 4-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313). Ferulic acid 4-O-glucuronide was found to be elevated in rat urine after whole rye consumption which makes this compound a potential urinary biomarker of whole grain intake (PMID: 26862900).

   

Feruloyl C1-glucuronide

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-{[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}oxane-2-carboxylic acid

C16H18O10 (370.09)


Feruloyl C1-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).

   

Isoferulic acid 3-O-glucuronide

(2S,3S,4S,5R,6S)-6-{5-[(1E)-2-carboxyeth-1-en-1-yl]-2-methoxyphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C16H18O10 (370.09)


Isoferulic acid 3-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).

   

Isoferuloyl C1-glucuronide

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-{[(2E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoyl]oxy}oxane-2-carboxylic acid

C16H18O10 (370.09)


Isoferuloyl C1-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).

   

cis-Ferulic acid 4-glucuronide

6-[4-(2-carboxyeth-1-en-1-yl)-2-methoxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C16H18O10 (370.09)


   

Fraxin

7-hydroxy-6-methoxy-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2H-chromen-2-one

C16H18O10 (370.09)


   
   

6,7-Dihydroxy-5-methoxycoumarin 6-beta-D-glucopyranoside

6,7-Dihydroxy-5-methoxycoumarin 6-beta-D-glucopyranoside

C16H18O10 (370.09)


   
   

(E)-3-[6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,3-benzodioxol-5-yl]prop-2-enoic acid

(E)-3-[6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,3-benzodioxol-5-yl]prop-2-enoic acid

C16H18O10 (370.09)


   
   

2,3,6,7,8,9-hexahydroxynaphthalene-2-O-alpha-L-(-)-rhamnopyranoside|arjunaphthanoloside

2,3,6,7,8,9-hexahydroxynaphthalene-2-O-alpha-L-(-)-rhamnopyranoside|arjunaphthanoloside

C16H18O10 (370.09)


   

pleospdione

pleospdione

C16H18O10 (370.09)


   

isofraxetin 6-O-beta-D-glucopyranoside

isofraxetin 6-O-beta-D-glucopyranoside

C16H18O10 (370.09)


   

5,8-dihydroxy-7-methoxycoumarin-5-beta-glucopyranoside

5,8-dihydroxy-7-methoxycoumarin-5-beta-glucopyranoside

C16H18O10 (370.09)


   

11-O-acetylbergenin

11-O-acetylbergenin

C16H18O10 (370.09)


   

Monnieriside A

Monnierisides A

C16H18O10 (370.09)


Monnieriside A is a natural product found in Cnidium monnieri with data available.

   
   
   

2-methyl-5,7-dihydroxychromone 8-C-beta-D-glucopyranoside

2-methyl-5,7-dihydroxychromone 8-C-beta-D-glucopyranoside

C16H18O10 (370.09)


   

daphkoreanin

daphkoreanin

C16H18O10 (370.09)


   

8-hydroxy-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one

NCGC00386042-01!8-hydroxy-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one

C16H18O10 (370.09)


   

7-hydroxy-6-methoxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one

NCGC00169184-02!7-hydroxy-6-methoxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one

C16H18O10 (370.09)


   

C16H18O10

NCGC00380533-01_C16H18O10_

C16H18O10 (370.09)


   

8-hydroxy-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one

8-hydroxy-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one

C16H18O10 (370.09)


   
   

7-hydroxy-6-methoxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one [IIN-based: Match]

NCGC00169184-02!7-hydroxy-6-methoxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one [IIN-based: Match]

C16H18O10 (370.09)


   

8-hydroxy-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one_major

8-hydroxy-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one_major

C16H18O10 (370.09)


   

fraxin_major

fraxin_major

C16H18O10 (370.09)


   

Remoxipride

Remoxiprida [INN-Spanish];Remoxipride [Usan:Ban:Inn];Remoxipridum [INN-Latin];Romoxipride

C16H23BrN2O3 (370.0892)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AL - Benzamides C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

   

5-Hydroxy-6-methoxycoumarin 7-glucoside

5-hydroxy-6-methoxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2H-chromen-2-one

C16H18O10 (370.09)


   

Ferulic acid 4-O-glucuronide

(2S,3S,4S,5R,6S)-6-{4-[(1E)-2-carboxyeth-1-en-1-yl]-2-methoxyphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C16H18O10 (370.09)


   

Feruloyl C1-glucuronide

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-{[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}oxane-2-carboxylic acid

C16H18O10 (370.09)


   

Isoferulic acid 3-O-glucuronide

(2S,3S,4S,5R,6S)-6-{5-[(1E)-2-carboxyeth-1-en-1-yl]-2-methoxyphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C16H18O10 (370.09)


   

Isoferuloyl C1-glucuronide

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-{[(2E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoyl]oxy}oxane-2-carboxylic acid

C16H18O10 (370.09)


   

6-chloro-3-indoxyl-n-acetyl-beta-d-galactosaminide

6-chloro-3-indoxyl-n-acetyl-beta-d-galactosaminide

C16H19ClN2O6 (370.0932)


   

Phosphonium,(2-carboxyethyl)triphenyl-, chloride (1:1)

Phosphonium,(2-carboxyethyl)triphenyl-, chloride (1:1)

C21H20ClO2P (370.0889)


   

Decamethylcyclopentasiloxane

Decamethylcyclopentasiloxane

C10H30O5Si5 (370.094)


D001697 - Biomedical and Dental Materials

   

2-(4-BROMOPHENYL)-PROPANEDIOIC ACID 1,3-BIS-T-BUTYL ESTER

2-(4-BROMOPHENYL)-PROPANEDIOIC ACID 1,3-BIS-T-BUTYL ESTER

C17H23BrO4 (370.078)


   

L-Tryptophan,N-(2,4-dinitrophenyl)-

L-Tryptophan,N-(2,4-dinitrophenyl)-

C17H14N4O6 (370.0913)


   

carbomethoxymethyl triphenylphosphonium chloride

carbomethoxymethyl triphenylphosphonium chloride

C21H20ClO2P (370.0889)


   

bis(ethylcyclopentadienyl)tungsten dihydride

bis(ethylcyclopentadienyl)tungsten dihydride

C14H18W (370.0918)


   

1H-Pyrrolo[2,3-b]pyridine, 5-bromo-4-fluoro-1-[tris(1-methylethyl)silyl]-

1H-Pyrrolo[2,3-b]pyridine, 5-bromo-4-fluoro-1-[tris(1-methylethyl)silyl]-

C16H24BrFN2Si (370.0876)


   

(-)-(2S,3S)-2,3-Epoxy-3-cyclohexyl-1-propanol

(-)-(2S,3S)-2,3-Epoxy-3-cyclohexyl-1-propanol

C16H23BrN2O3 (370.0892)


   

Premarin

Premarin

C18H19NaO5S (370.0851)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen

   

2,3-BIS(4-FLUOROPHENYL)-5-PHENYLTETRAZOLIUM CHLORIDE

2,3-BIS(4-FLUOROPHENYL)-5-PHENYLTETRAZOLIUM CHLORIDE

C19H13ClF2N4 (370.0797)


   

2,3-BIS(3-FLUOROPHENYL)-5-PHENYLTETRAZOLIUMCHLORIDE

2,3-BIS(3-FLUOROPHENYL)-5-PHENYLTETRAZOLIUMCHLORIDE

C19H13ClF2N4 (370.0797)


   

6-CHLORO-3-INDOXYL-N-ACETYL-β-D-GLUCOSAMINIDE

6-CHLORO-3-INDOXYL-N-ACETYL-β-D-GLUCOSAMINIDE

C16H19ClN2O6 (370.0932)


   

FLUORESCEIN O-ACRYLATE

FLUORESCEIN O-ACRYLATE

C23H14O5 (370.0841)


   

Isofraxoside

Isofraxoside

C16H18O10 (370.09)


   

4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-YL)amino]methyl}phenyl sulfamate

4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-YL)amino]methyl}phenyl sulfamate

C16H14N6O3S (370.0848)


   

N-(4-acetamidophenyl)-3-(5-chloro-2-hydroxyphenyl)-1H-pyrazole-5-carboxamide

N-(4-acetamidophenyl)-3-(5-chloro-2-hydroxyphenyl)-1H-pyrazole-5-carboxamide

C18H15ClN4O3 (370.0833)


   

cis-Ferulic acid 4-glucuronide

cis-Ferulic acid 4-glucuronide

C16H18O10 (370.09)


   

N-(2-hydroxyethyl)-4-[2-nitro-4-(trifluoromethyl)phenoxy]benzamide

N-(2-hydroxyethyl)-4-[2-nitro-4-(trifluoromethyl)phenoxy]benzamide

C16H13F3N2O5 (370.0777)


   

1-O-[N-(2-hydroxybenzoyl)glycyl]-beta-D-glucuronate

1-O-[N-(2-hydroxybenzoyl)glycyl]-beta-D-glucuronate

C15H16NO10- (370.0774)


   

6-[3-[(E)-2-carboxyethenyl]-5-methoxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[3-[(E)-2-carboxyethenyl]-5-methoxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C16H18O10 (370.09)


   

Thyrsifloside

Thyrsifloside

C16H18O10 (370.09)


   

Thiophanate

Thiophanate

C14H18N4O4S2 (370.0769)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D016573 - Agrochemicals D010575 - Pesticides

   

Premarin

Sodium equilin sulfate

C18H19O5S. Na (370.0851)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen

   

(1r,3r,4s,6r,7r)-4-bromo-3-ethyl-9-[(2z)-pent-2-en-4-yn-1-yl]-2,8-dioxabicyclo[5.2.1]decan-6-yl acetate

(1r,3r,4s,6r,7r)-4-bromo-3-ethyl-9-[(2z)-pent-2-en-4-yn-1-yl]-2,8-dioxabicyclo[5.2.1]decan-6-yl acetate

C17H23BrO4 (370.078)


   

8-hydroxy-7-methoxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

8-hydroxy-7-methoxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

C16H18O10 (370.09)


   

(1r,3r,4s,6r,7r,9r)-4-bromo-3-ethyl-9-[(2e)-pent-2-en-4-yn-1-yl]-2,8-dioxabicyclo[5.2.1]decan-6-yl acetate

(1r,3r,4s,6r,7r,9r)-4-bromo-3-ethyl-9-[(2e)-pent-2-en-4-yn-1-yl]-2,8-dioxabicyclo[5.2.1]decan-6-yl acetate

C17H23BrO4 (370.078)


   

(1r,2s,3r,4s)-11-(diazyn-1-ium-1-yl)-1,2,3,4,10-pentahydroxy-2-methyl-5-oxo-1h,3h,4h-benzo[b]fluoren-9-olate

(1r,2s,3r,4s)-11-(diazyn-1-ium-1-yl)-1,2,3,4,10-pentahydroxy-2-methyl-5-oxo-1h,3h,4h-benzo[b]fluoren-9-olate

C18H14N2O7 (370.0801)


   

8-hydroxy-6-methoxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

8-hydroxy-6-methoxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

C16H18O10 (370.09)


   

(11r)-11-(2-carbamimidamidoethyl)-8-hydroxy-13-oxo-12,15-dioxa-4-azatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadeca-1(16),2,4,6,8,10(14)-hexaene-3-carboxylic acid

(11r)-11-(2-carbamimidamidoethyl)-8-hydroxy-13-oxo-12,15-dioxa-4-azatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadeca-1(16),2,4,6,8,10(14)-hexaene-3-carboxylic acid

C17H14N4O6 (370.0913)


   

(1r,2r,3s,4s)-1,2,3,4,9-pentahydroxy-2-methyl-11-(λ⁵-diazynylidene)-1h,3h,4h-benzo[b]fluorene-5,10-dione

(1r,2r,3s,4s)-1,2,3,4,9-pentahydroxy-2-methyl-11-(λ⁵-diazynylidene)-1h,3h,4h-benzo[b]fluorene-5,10-dione

C18H14N2O7 (370.0801)


   

7-hydroxy-5-methoxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

7-hydroxy-5-methoxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

C16H18O10 (370.09)


   

11-(2-carbamimidamidoethyl)-8-hydroxy-13-oxo-12,15-dioxa-4-azatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadeca-1(16),2,4,6,8,10(14)-hexaene-3-carboxylic acid

11-(2-carbamimidamidoethyl)-8-hydroxy-13-oxo-12,15-dioxa-4-azatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadeca-1(16),2,4,6,8,10(14)-hexaene-3-carboxylic acid

C17H14N4O6 (370.0913)


   

5-hydroxy-6-methoxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

5-hydroxy-6-methoxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

C16H18O10 (370.09)


   

1,2,3,4,9-pentahydroxy-2-methyl-11-(λ⁵-diazynylidene)-1h,3h,4h-benzo[b]fluorene-5,10-dione

1,2,3,4,9-pentahydroxy-2-methyl-11-(λ⁵-diazynylidene)-1h,3h,4h-benzo[b]fluorene-5,10-dione

C18H14N2O7 (370.0801)


   

7-hydroxy-6-methoxy-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

7-hydroxy-6-methoxy-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

C16H18O10 (370.09)


   

(1r,3r,4s,6r,7r)-4-bromo-3-ethyl-9-(pent-2-en-4-yn-1-yl)-2,8-dioxabicyclo[5.2.1]decan-6-yl acetate

(1r,3r,4s,6r,7r)-4-bromo-3-ethyl-9-(pent-2-en-4-yn-1-yl)-2,8-dioxabicyclo[5.2.1]decan-6-yl acetate

C17H23BrO4 (370.078)


   

8-hydroxy-7-methoxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

8-hydroxy-7-methoxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

C16H18O10 (370.09)


   

8-hydroxy-6-methoxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

8-hydroxy-6-methoxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

C16H18O10 (370.09)


   

(1r,3r,4s,6r,7r,9r)-4-bromo-3-ethyl-9-(pent-2-en-4-yn-1-yl)-2,8-dioxabicyclo[5.2.1]decan-6-yl acetate

(1r,3r,4s,6r,7r,9r)-4-bromo-3-ethyl-9-(pent-2-en-4-yn-1-yl)-2,8-dioxabicyclo[5.2.1]decan-6-yl acetate

C17H23BrO4 (370.078)